GSA Capital Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $666K | Buy |
2,276
+1,656
| +267% | +$544K | 0.04% | 738 |
|
|
2025
Q4 | $217K | Sell |
620
-1,463
| -70% | -$494K | 0.02% | 1361 |
|
|
2025
Q3 | $673K | Buy |
2,083
+919
| +79% | +$286K | 0.06% | 653 |
|
|
2025
Q2 | $453K | Buy |
+1,164
| New | +$468K | 0.03% | 992 |
|
|
2025
Q1 | – | Sell |
-2,451
| Closed | -$904K | – | 1764 |
|
|
2024
Q4 | $904K | Buy |
2,451
+1,455
| +146% | +$609K | 0.07% | 477 |
|
|
2024
Q3 | $518K | Buy |
+996
| New | +$532K | 0.04% | 875 |
|
|
2023
Q4 | – | Sell |
-611
| Closed | -$266K | – | 1599 |
|
|
2023
Q3 | $266K | Sell |
611
-390
| -39% | -$177K | 0.02% | 1144 |
|
|
2023
Q2 | $445K | Buy |
1,001
+65
| +7% | +$30K | 0.04% | 818 |
|
|
2023
Q1 | $430K | Buy |
+936
| New | +$445K | 0.04% | 810 |
|
|
2022
Q4 | – | Sell |
-1,886
| Closed | -$857K | – | 1577 |
|
|
2022
Q3 | $857K | Buy |
+1,886
| New | +$902K | 0.11% | 229 |
|
|
2022
Q1 | – | Sell |
-438
| Closed | -$203K | – | 1521 |
|
|
2021
Q4 | $203K | Buy |
+438
| New | +$184K | 0.03% | 1222 |
|
|
2020
Q2 | – | Sell |
-901
| Closed | -$205K | – | 734 |
|
|
2020
Q1 | $205K | Buy |
+901
| New | +$246K | 0.05% | 743 |
|
|
2019
Q4 | – | Sell |
-4,524
| Closed | -$1.09M | – | 1501 |
|
|
2019
Q3 | $1.09M | Buy |
+4,524
| New | +$1.24M | 0.15% | 133 |
|
|
2019
Q2 | – | Sell |
-17,532
| Closed | -$5.03M | – | 1517 |
|
|
2019
Q1 | $5.03M | Buy |
17,532
+16,646
| +1,879% | +$4.81M | 0.51% | 6 |
|
|
2018
Q4 | $233K | Buy |
+886
| New | +$244K | 0.03% | 1006 |
|
|
2018
Q2 | – | Sell |
-5,913
| Closed | -$1.3M | – | 1744 |
|
|
2018
Q1 | $1.3M | Buy |
+5,913
| New | +$1.39M | 0.07% | 498 |
|
|
2017
Q3 | – | Sell |
-5,342
| Closed | -$1M | – | 1679 |
|
|
2017
Q2 | $1M | Buy |
+5,342
| New | +$960K | 0.07% | 536 |
|
|
2017
Q1 | – | Sell |
-1,752
| Closed | -$252K | – | 1801 |
|
|
2016
Q4 | $252K | Sell |
1,752
-21,327
| -92% | -$2.86M | 0.02% | 1441 |
|
|
2016
Q3 | $2.89M | Sell |
23,079
-4,444
| -16% | -$574K | 0.16% | 114 |
|
|
2016
Q2 | $3.62M | Buy |
27,523
+17,420
| +172% | +$2.38M | 0.2% | 53 |
|
|
2016
Q1 | $1.4M | Buy |
+10,103
| New | +$1.35M | 0.09% | 362 |
|
|
2015
Q4 | – | Sell |
-26,312
| Closed | -$3.68M | – | 1847 |
|
|
2015
Q3 | $3.68M | Buy |
26,312
+10,340
| +65% | +$1.55M | 0.18% | 76 |
|
|
2015
Q2 | $2.62M | Sell |
15,972
-3,704
| -19% | -$592K | 0.1% | 219 |
|
|
2015
Q1 | $3.04M | Sell |
19,676
-6,051
| -24% | -$862K | 0.12% | 158 |
|
|
2014
Q4 | $3.23M | Buy |
+25,727
| New | +$3.18M | 0.23% | 43 |
|
|
2014
Q3 | – | Sell |
-49,369
| Closed | -$5.31M | – | 1763 |
|
|
2014
Q2 | $5.31M | Buy |
49,369
+38,701
| +363% | +$3.99M | 0.24% | 56 |
|
|
2014
Q1 | $1.06M | Buy |
10,668
+6,800
| +176% | +$615K | 0.08% | 299 |
|
|
2013
Q4 | $357K | Sell |
3,868
-29,667
| -88% | -$2.64M | 0.03% | 1085 |
|
|
2013
Q3 | $2.8M | Buy |
+33,535
| New | +$2.87M | 0.22% | 74 |
|
Other funds holding ELV
VCM
VPM
GSA Capital Partners's ELV Position: Q1 2026 in Review
GSA Capital Partners increased its Elevance Health (ELV) stake by 267% in Q1 2026, buying an estimated $544K and bringing the position to 2,276 shares worth $666K. The position accounts for 0.04% of the portfolio, ranked #738.
GSA Capital Partners first reported a position in ELV in Q3 2013 and has held it in 29 quarters since. The position peaked at $5.31M in Q2 2014. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- GSA Capital Partners held 2,276 shares of Elevance Health worth $666K as of Q1 2026.
- GSA Capital Partners bought 1,656 Elevance Health shares in Q1 2026, an estimated $544K.
- Elevance Health made up 0.04% of GSA Capital Partners's portfolio in Q1 2026, its #738 holding.
- GSA Capital Partners first reported a position in Elevance Health in Q3 2013 and has held it in 29 quarters since.
- GSA Capital Partners's Elevance Health position peaked at $5.31M in Q2 2014.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.